|
NOSIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.429600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.261800E-01 |
| Normal-vs-Stage2 |
2.299600E-01 |
| Normal-vs-Stage3 |
1.463630E-01 |
| Normal-vs-Stage4 |
7.673600E-01 |
| Stage1-vs-Stage2 |
6.188400E-01 |
| Stage1-vs-Stage3 |
5.834600E-01 |
| Stage1-vs-Stage4 |
5.702000E-02 |
| Stage2-vs-Stage3 |
9.004600E-01 |
| Stage2-vs-Stage4 |
1.422970E-01 |
| Stage3-vs-Stage4 |
5.916100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.302160E-01 |
| Normal-vs-AfricanAmerican |
9.385200E-01 |
| Normal-vs-Asian |
2.395000E-01 |
| Caucasian-vs-AfricanAmerican |
3.223600E-01 |
| Caucasian-vs-Asian |
9.261400E-01 |
| AfricanAmerican-vs-Asian |
3.151800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.722300E-02 |
| Normal-vs-Female |
3.621600E-01 |
| Male-vs-Female |
2.101600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.870500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.407600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.250800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.897400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.715200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.204400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.132200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.558600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.047000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.667000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.225950E-01 |
| Classical-VS-Follicular |
9.647800E-01 |
| Classical-VS-Other |
9.164600E-01 |
| Classical-VS-Normal |
2.230000E-01 |
| Tall-VS-Follicular |
1.892810E-01 |
| Tall-VS-Other |
4.828000E-01 |
| Tall-VS-Normal |
5.896200E-01 |
| Follicular-VS-Other |
8.550800E-01 |
| Follicular-VS-Normal |
2.681400E-01 |
| Other-VS-Normal |
6.505000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.922100E-02 |
| Normal-vs-N1 |
4.469000E-01 |
| N0-vs-N1 |
3.932000E-01 |
|
|
